160 related articles for article (PubMed ID: 30851617)
1. Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method.
Kotwal P; Magotra A; Dogra A; Sharma S; Gour A; Bhatt S; Wazir P; Singh PP; Singh G; Nandi U
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():48-55. PubMed ID: 30851617
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an LC-MS/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasma.
Gray WA; Waldorf B; Rao MG; Stiles BL; Griffiss JM; Salata RA; Blumer JL
J Pharm Biomed Anal; 2019 Nov; 176():112775. PubMed ID: 31446299
[TBL] [Abstract][Full Text] [Related]
3. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions.
van Heeswijk RP; Dannemann B; Hoetelmans RM
J Antimicrob Chemother; 2014 Sep; 69(9):2310-8. PubMed ID: 24860154
[TBL] [Abstract][Full Text] [Related]
4. Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry.
Alffenaar JW; Bolhuis M; van Hateren K; Sturkenboom M; Akkerman O; de Lange W; Greijdanus B; van der Werf T; Touw D
Antimicrob Agents Chemother; 2015 Sep; 59(9):5675-80. PubMed ID: 26149993
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
[TBL] [Abstract][Full Text] [Related]
6. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
Chahine EB; Karaoui LR; Mansour H
Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug.
Svensson EM; Murray S; Karlsson MO; Dooley KE
J Antimicrob Chemother; 2015 Apr; 70(4):1106-14. PubMed ID: 25535219
[TBL] [Abstract][Full Text] [Related]
8. Effect of Natural Phenolics on Pharmacokinetic Modulation of Bedaquiline in Rat to Assess the Likelihood of Potential Food-Drug Interaction.
Kotwal P; Dogra A; Sharma A; Bhatt S; Gour A; Sharma S; Wazir P; Singh PP; Kumar A; Nandi U
J Agric Food Chem; 2020 Feb; 68(5):1257-1265. PubMed ID: 31927919
[TBL] [Abstract][Full Text] [Related]
9. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
Worley MV; Estrada SJ
Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
[TBL] [Abstract][Full Text] [Related]
10. Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis.
Brill MJ; Svensson EM; Pandie M; Maartens G; Karlsson MO
Int J Antimicrob Agents; 2017 Feb; 49(2):212-217. PubMed ID: 28038962
[TBL] [Abstract][Full Text] [Related]
11. Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study.
Bratkowska D; Shobo A; Singh S; A Bester L; Kruger HG; Maguire GE; Govender T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():187-94. PubMed ID: 25796075
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study.
Kurosawa K; Rossenu S; Biewenga J; Ouwerkerk-Mahadevan S; Willems W; Ernault E; Kambili C
J Clin Pharmacol; 2021 Oct; 61(10):1344-1355. PubMed ID: 33991350
[TBL] [Abstract][Full Text] [Related]
13. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
Mudavath S; Ashok D
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
[TBL] [Abstract][Full Text] [Related]
14. Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.
Nguyen TV; Cao TB; Akkerman OW; Tiberi S; Vu DH; Alffenaar JW
Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1025-37. PubMed ID: 27322153
[TBL] [Abstract][Full Text] [Related]
15. Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
Perrineau S; Lachâtre M; Lê MP; Rioux C; Loubet P; Fréchet-Jachym M; Gonzales MC; Grall N; Bouvet E; Veziris N; Yazdanpanah Y; Peytavin G
Int J Tuberc Lung Dis; 2019 Jan; 23(1):99-104. PubMed ID: 30674381
[TBL] [Abstract][Full Text] [Related]
16. Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.
Healan AM; Griffiss JM; Proskin HM; O'Riordan MA; Gray WA; Salata RA; Blumer JL
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061739
[TBL] [Abstract][Full Text] [Related]
17. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
Hu M; Zheng C; Gao F
Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
[TBL] [Abstract][Full Text] [Related]
18. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
Centers for Disease Control and Prevention
MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
20. Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
Xu J; Tasneen R; Peloquin CA; Almeida DV; Li SY; Barnes-Boyle K; Lu Y; Nuermberger E
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
